841 LBL-019, a novel TNFR2 agonist antibody, shows potent anti-tumor efficacy through preferentially activating CD8+ T cells and alleviating the suppressive effect of Treg cells
Wang, Baohui, Wang, Hailin, Li, Tingting, Sun, Jianming, Huang, Xiao, Lin, Huan, Dan, Yujia, Qin, Yurong, Zhang, Peng, Guan, Jing, Wu, Guojin, Hou, Xiaofan, Lai, Shoupeng, Kang, Xiaoqiang, Ling, Hong
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
Human monoclonal antibodies as candidate therapeutics against emerging viruses
Jin, Yujia, Lei, Cheng, Hu, Dan, Dimitrov, Dimiter S., Ying, Tianlei
Published in Frontiers of medicine (01.12.2017)
Published in Frontiers of medicine (01.12.2017)
Get full text
Journal Article